Surfactant proteins are important functional components of pulmonary surfactant, a complex lipoprotein that acts to reduce lung alveolar surface tension. Expression of the genes encoding surfactant proteins, SP-A, SP-B, SP-C, and SP-D is developmentally regulated in fetal lung tissue. Prematurely born infants can develop Respiratory Distress Syndrome (RDS), due to a lack of adequate surfactant synthesis. RDS is the leading cause of neonatal morbidity and mortality in developed countries. Treatment of infants and pregnant mothers with glucocorticoids accelerates lung maturity, decreasing the risk of RDS. Surfactant protein B (SP-B) is a critical component in the function of surfactant. Surfactant that is deficient in SP-B protein results respiratory failure in full term infants, and surfactant that contains reduced levels of SP-B protein is not effective in the ability to reduce lung alveolar surface tension. Glucocorticoids alter surfactant protein expression in fetal human lung via both transcriptional activation and by altering the stability of surfactant protein mRNA. In particular, glucocorticoids increase both the transcriptional expression and the stability of SP-B mRNA. Since glucocorticoids are used clinically in treatment of premature infants, it is important to understand the molecular mechanism(s) by which glucocorticoids act to regulate surfactant protein gene expression in type II epithelial cells in fetal lung. The objective of the proposed research is to define the molecular mechanism(s) by which glucocorticoids stabilize human SP-B mRNA while destabilizing SP- A mRNA. The following specific aims are proposed: (1) functionally localize the region(s) in the SP-B mRNA that mediates regulation of human SP-B mRNA stability by glucocorticoids in vivo; (2) characterize the in vitro mRNA:protein interactions at the cis-acting element(s) that mediate regulation of human SP-B mRNA stability by glucocorticoids; and (3) identify the protein(s) that mediates regulation of human SP-B mRNA stability and study its regulation. The goal of this research is to define the molecular mechanisms whereby glucocorticoids enhance SP-B gene expression and reduce SP-A gene expression by post-transcriptional mechanisms during fetal lung development and, therefore provide insight into the design of treatment regimens that increase the effectiveness of antenatal glucocorticoids in the enhancement of surfactant synthesis by the fetal lung and prevent RDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL068116-04
Application #
6786059
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Berberich, Mary Anne
Project Start
2001-08-15
Project End
2007-07-31
Budget Start
2004-08-01
Budget End
2007-07-31
Support Year
4
Fiscal Year
2004
Total Cost
$297,000
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Pediatrics
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Huang, Helen W; Payne, David E; Bi, Weizhen et al. (2012) Sequences of a hairpin structure in the 3'-untranslated region mediate regulation of human pulmonary surfactant protein B mRNA stability. Am J Physiol Lung Cell Mol Physiol 302:L1107-17
Das, Aparajita; Acharya, Sunil; Gottipati, Koteswara Rao et al. (2011) Thyroid transcription factor-1 (TTF-1) gene: identification of ZBP-89, Sp1, and TTF-1 sites in the promoter and regulation by TNF-? in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 301:L427-40
Tillis, CeĆ” C; Huang, Helen W; Bi, Weizhen et al. (2011) Glucocorticoid regulation of human pulmonary surfactant protein-B (SP-B) mRNA stability is independent of activated glucocorticoid receptor. Am J Physiol Lung Cell Mol Physiol 300:L940-50
Bruce, Shirley R; Atkins, Constance L; Colasurdo, Giuseppe N et al. (2009) Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. Am J Physiol Lung Cell Mol Physiol 297:L559-67
Alcorn, Joseph L; Merritt, Thomas M; Farach-Carson, Mary C et al. (2009) Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein. RNA 15:686-95
Huang, Helen W; Bi, Weizhen; Jenkins, Gaye N et al. (2008) Glucocorticoid regulation of human pulmonary surfactant protein-B mRNA stability involves the 3'-untranslated region. Am J Respir Cell Mol Biol 38:473-82
Alcorn, Joseph L; Stark, James M; Chiappetta, Constance L et al. (2005) Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: contrasting consequences on SP-A mRNA and protein. Am J Physiol Lung Cell Mol Physiol 289:L1113-22
Sacks, Michael S (2003) Incorporation of experimentally-derived fiber orientation into a structural constitutive model for planar collagenous tissues. J Biomech Eng 125:280-7